297 related articles for article (PubMed ID: 25062763)
1. Changes in cognitive control in pre-manifest Huntington's disease examined using pre-saccadic EEG potentials - a longitudinal study.
Ness V; Bestgen AK; Saft C; Beste C
J Huntingtons Dis; 2014; 3(1):33-43. PubMed ID: 25062763
[TBL] [Abstract][Full Text] [Related]
2. Saccadic impairments in Huntington's disease.
Peltsch A; Hoffman A; Armstrong I; Pari G; Munoz DP
Exp Brain Res; 2008 Apr; 186(3):457-69. PubMed ID: 18185924
[TBL] [Abstract][Full Text] [Related]
3. Oculomotor deficits indicate the progression of Huntington's disease.
Hicks SL; Robert MP; Golding CV; Tabrizi SJ; Kennard C
Prog Brain Res; 2008; 171():555-8. PubMed ID: 18718352
[TBL] [Abstract][Full Text] [Related]
4. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
[TBL] [Abstract][Full Text] [Related]
5. Eye-head coordination in moderately affected Huntington's Disease patients: do head movements facilitate gaze shifts?
Becker W; Jürgens R; Kassubek J; Ecker D; Kramer B; Landwehrmeyer B
Exp Brain Res; 2009 Jan; 192(1):97-112. PubMed ID: 18807023
[TBL] [Abstract][Full Text] [Related]
6. Saccadic eye movements in juvenile variant of Huntington disease.
Grabska N; Rudzińska M; Wójcik-Pędziwiatr M; Michalski M; Sławek J; Szczudlik A
Neurol Neurochir Pol; 2014; 48(4):236-41. PubMed ID: 25168321
[TBL] [Abstract][Full Text] [Related]
7. Saccades in presymptomatic and early stages of Huntington disease.
Blekher T; Johnson SA; Marshall J; White K; Hui S; Weaver M; Gray J; Yee R; Stout JC; Beristain X; Wojcieszek J; Foroud T
Neurology; 2006 Aug; 67(3):394-9. PubMed ID: 16855205
[TBL] [Abstract][Full Text] [Related]
8. The effect of impulsivity and inhibitory control deficits in the saccadic behavior of premanifest Huntington's disease individuals.
Júlio F; Caetano G; Januário C; Castelo-Branco M
Orphanet J Rare Dis; 2019 Nov; 14(1):246. PubMed ID: 31703597
[TBL] [Abstract][Full Text] [Related]
9. Alterations in voluntary movement execution in Huntington's disease are related to the dominant motor system: evidence from event-related potentials.
Beste C; Konrad C; Saft C; Ukas T; Andrich J; Pfleiderer B; Hausmann M; Falkenstein M
Exp Neurol; 2009 Mar; 216(1):148-57. PubMed ID: 19111540
[TBL] [Abstract][Full Text] [Related]
10. Saccadometry of conditional rules in presymptomatic Huntington's disease.
Robert MP; Nachev PC; Hicks SL; Golding CV; Tabrizi SJ; Kennard C
Ann N Y Acad Sci; 2009 May; 1164():444-50. PubMed ID: 19645945
[TBL] [Abstract][Full Text] [Related]
11. Using temporally aligned event-related potentials for the investigation of attention shifts prior to and during saccades.
Huber-Huber C; Ditye T; Marchante Fernández M; Ansorge U
Neuropsychologia; 2016 Nov; 92():129-141. PubMed ID: 27059211
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Electroencephalographic Analysis Provides an Early-Stage Indicator of Disease Onset and Progression in the zQ175 Knock-In Mouse Model of Huntington's Disease.
Fisher SP; Schwartz MD; Wurts-Black S; Thomas AM; Chen TM; Miller MA; Palmerston JB; Kilduff TS; Morairty SR
Sleep; 2016 Feb; 39(2):379-91. PubMed ID: 26446107
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in Huntington's disease: a comparative study investigating the impact for those with pre-manifest and early manifest disease, and their partners.
Read J; Jones R; Owen G; Leavitt BR; Coleman A; Roos RA; Dumas EM; Durr A; Justo D; Say M; Stout JC; Tabrizi SJ; Craufurd D;
J Huntingtons Dis; 2013; 2(2):159-75. PubMed ID: 25063513
[TBL] [Abstract][Full Text] [Related]
14. Quantitative longitudinal assessment of saccades in Huntington's disease.
Rubin AJ; King WM; Reinbold KA; Shoulson I
J Clin Neuroophthalmol; 1993 Mar; 13(1):59-66. PubMed ID: 8501265
[TBL] [Abstract][Full Text] [Related]
15. On the role of fronto-striatal neural synchronization processes for response inhibition--evidence from ERP phase-synchronization analyses in pre-manifest Huntington's disease gene mutation carriers.
Beste C; Ness V; Falkenstein M; Saft C
Neuropsychologia; 2011 Oct; 49(12):3484-93. PubMed ID: 21906607
[TBL] [Abstract][Full Text] [Related]
16. The use of quantitative oculometry in the assessment of Huntington's disease.
Ali FR; Michell AW; Barker RA; Carpenter RH
Exp Brain Res; 2006 Feb; 169(2):237-45. PubMed ID: 16273398
[TBL] [Abstract][Full Text] [Related]
17. The peripheral preview effect with faces: Combined EEG and eye-tracking suggests multiple stages of trans-saccadic predictive and non-predictive processing.
Huber-Huber C; Buonocore A; Dimigen O; Hickey C; Melcher D
Neuroimage; 2019 Oct; 200():344-362. PubMed ID: 31260837
[TBL] [Abstract][Full Text] [Related]
18. The effects of antipsychotic medication on saccadic eye movement abnormalities in Huntington's disease.
Dursun SM; Burke JG; Andrews H; Mlynik-Szmid A; Reveley MA
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug; 24(6):889-96. PubMed ID: 11041532
[TBL] [Abstract][Full Text] [Related]
19. Reflexive and voluntary saccadic eye movements as biomarker of Huntington's Disease.
Grabska N; Wójcik-Pędziwiatr M; Sławek J; Sołtan W; Gawryluk J; Rudziński M; Szczudlik A; Rudzińska-Bar M
Neurol Neurochir Pol; 2024 May; ():. PubMed ID: 38818957
[TBL] [Abstract][Full Text] [Related]
20. Voluntary saccade inhibition deficits correlate with extended white-matter cortico-basal atrophy in Huntington's disease.
Vaca-Palomares I; Coe BC; Brien DC; Campos-Romo A; Munoz DP; Fernandez-Ruiz J
Neuroimage Clin; 2017; 15():502-512. PubMed ID: 28649493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
